LAM
MD icon

Lountzis Asset Management’s Pediatrix Medical MD Stock Holding History

Lountzis Asset Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40
Closed -$1.14K – 64
2021
Q3 		$1.14K Buy
+40
New +$1.22K ﹤0.01% 96

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Lountzis Asset Management's MD Position: Q4 2021 in Review

Lountzis Asset Management sold out of Pediatrix Medical (MD) in Q4 2021, closing a stake of 40 shares — an estimated $1.14K sold.

Lountzis Asset Management first reported a position in MD in Q3 2021 and held it in 1 quarter. The position peaked at $1.14K in Q3 2021. 204 funds tracked by Wall St. Rank hold MD as of Q4 2021.

  • Lountzis Asset Management reported no remaining Pediatrix Medical position as of Q4 2021 after selling out during the quarter.
  • Lountzis Asset Management sold 40 Pediatrix Medical shares in Q4 2021, an estimated $1.14K.
  • Lountzis Asset Management first reported a position in Pediatrix Medical in Q3 2021 and held it in 1 quarter.
  • Lountzis Asset Management's Pediatrix Medical position peaked at $1.14K in Q3 2021.
  • 204 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2021.

Based on Lountzis Asset Management's 13F filing for Q4 2021, filed 26 Jan 2022.